(Q44551426)

4 December 2017

title

Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors (English)

1 reference

4 December 2017

Mary E Temple

1

1 reference

4 December 2017

Katalin I Koranyi

series ordinal

2

1 reference

4 December 2017

Milap C Nahata

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Annals of Pharmacotherapy

4 December 2017

published in

1 reference

4 December 2017

volume

37

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

1214-1218

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

4 December 2017

cites work

1 reference

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

Hyperlipidemia associated with protease inhibitor therapy

21 January 2018

1 reference

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

21 January 2018

1 reference

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

21 January 2018

1 reference

Insulin resistance in HIV protease inhibitor-associated diabetes

21 January 2018

1 reference

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

Indinavir-associated lipodystrophy.

21 January 2018

1 reference

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

21 January 2018

1 reference

Localized adipose tissue hypertrophy in patients receiving human immunodeficiency virus protease inhibitors

21 January 2018

1 reference

Lipodystrophy syndrome in children infected with human immunodeficiency virus

21 January 2018

1 reference

Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine

21 January 2018

1 reference

Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children

21 January 2018

1 reference

HIV-1 protease inhibitor-associated partial lipodystrophy: clinicopathologic review of 14 cases

21 January 2018

1 reference

Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy

21 January 2018

1 reference

Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy

21 January 2018

1 reference

Lipodystrophy syndrome in human immunodeficiency virus-infected children

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A444

1 reference

4 December 2017

1 reference